Fifth Third Bancorp’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-26
Closed -$334 2608
2023
Q3
$334 Sell
26
-451
-95% -$8.11K ﹤0.01% 2533
2023
Q2
$8.62K Buy
477
+22
+5% +$411 ﹤0.01% 2031
2023
Q1
$7.62K Hold
455
﹤0.01% 2191
2022
Q4
$9.34K Buy
+455
New +$8.03K ﹤0.01% 1993
2022
Q2
Sell
-54
Closed -$2K 2748
2022
Q1
$2K Sell
54
-50
-48% -$1.61K ﹤0.01% 2537
2021
Q4
$3K Sell
104
-47
-31% -$1.57K ﹤0.01% 2496
2021
Q3
$6K Sell
151
-46
-23% -$1.83K ﹤0.01% 2162
2021
Q2
$8K Sell
197
-68
-26% -$2.87K ﹤0.01% 2086
2021
Q1
$11K Hold
265
﹤0.01% 1988
2020
Q4
$11K Buy
265
+215
+430% +$7.85K ﹤0.01% 1899
2020
Q3
$2K Buy
+50
New +$1.55K ﹤0.01% 2063
2020
Q1
Sell
-30
Closed -$1K 2250
2019
Q4
$1K Buy
+30
New +$1.41K ﹤0.01% 2146

Other funds holding OFIX

Fifth Third Bancorp's OFIX Position: Q4 2023 in Review

Fifth Third Bancorp sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 26 shares — an estimated $334 sold.

Fifth Third Bancorp first reported a position in OFIX in Q4 2019 and held it in 12 quarters. The position peaked at $11K in Q1 2021. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • Fifth Third Bancorp reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
  • Fifth Third Bancorp sold 26 Orthofix Medical shares in Q4 2023, an estimated $334.
  • Fifth Third Bancorp first reported a position in Orthofix Medical in Q4 2019 and held it in 12 quarters.
  • Fifth Third Bancorp's Orthofix Medical position peaked at $11K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on Fifth Third Bancorp's 13F filing for Q4 2023, filed 19 Jan 2024.